Anish Patel

CHIEF OPERATING OFFICER

Anish Patel (CHIEF OPERATING OFFICER) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Enliven Therapeutics, Inc. (ELVN). The largest single filing was $1.3M of ELVN (48,057 sh × $27.98, as filed), executed Jan 9.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 4 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$1.7M

shares × price, as filed

Last traded

Jan 9

Filed Jan 13

Median ADV $83.7M across their filed names

Open performance→

Volume by month

Buys $0 Sells $3.2M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 4 filings

Sector per market data · by filing · past 12 months

Most traded names

ELVN

Enliven Therapeutics, Inc. ELVN · 0 buys · 12 sells 12 filings

Recent filings

ELVNSALE Enliven Therapeutics, Inc. View filing → $1.3M
48,057 sh × $27.98
Exec Jan 9
Filed Jan 13 · 5:30 PM ET ELVNSALE Enliven Therapeutics, Inc. View filing → $103K
4,958 sh × $20.76
Exec Dec 8 2025
Filed Dec 10 2025 · 5:30 PM ET ELVNSALE Enliven Therapeutics, Inc. View filing → $105K
6,054 sh × $17.35
Exec Nov 7 2025
Filed Nov 12 2025 · 5:30 PM ET ELVNSALE Enliven Therapeutics, Inc. View filing → $134K
6,667 sh × $20.10
Exec Oct 7 2025
Filed Oct 9 2025 · 5:30 PM ET ELVNSALE Enliven Therapeutics, Inc. View filing → $135K
6,667 sh × $20.24
Exec Sep 8 2025
Filed Sep 10 2025 · 5:30 PM ET ELVNSALE Enliven Therapeutics, Inc. View filing → $114K
6,262 sh × $18.20
Exec Aug 7 2025
Filed Aug 11 2025 · 5:30 PM ET ELVNSALE Enliven Therapeutics, Inc. View filing → $126K
6,362 sh × $19.75
Exec Jul 7 2025
Filed Jul 9 2025 · 5:30 PM ET ELVNSALE Enliven Therapeutics, Inc. View filing → $134K
6,607 sh × $20.33
Exec Jun 9 2025
Filed Jun 11 2025 · 5:30 PM ET More filings →